Thermo Fisher Scientific INC (TMO) Holder Smith Salley & Associates Has Increased Stake

December 8, 2017 - By Hazel Jackson

Investors sentiment decreased to 0.91 in 2017 Q2. Its down 0.04, from 0.95 in 2017Q1. It is negative, as 43 investors sold TMO shares while 415 reduced holdings. 99 funds opened positions while 316 raised stakes. 323.23 million shares or 1.69% less from 328.77 million shares in 2017Q1 were reported. 79,462 are owned by Granite Invest Prtn Limited Liability Corporation. Lazard Asset Mgmt Ltd Limited Liability Company accumulated 0.38% or 1.05 million shares. Eagle Mgmt Ltd Liability stated it has 2.5% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Groesbeck Investment Mgmt Nj accumulated 3,875 shares. Lombard Odier Asset Mgmt (Europe) Ltd stated it has 5,101 shares or 0.05% of all its holdings. Liberty Cap Mngmt reported 19,168 shares. Horan Capital Lc stated it has 17,714 shares. Pennsylvania Trust, a Pennsylvania-based fund reported 41,950 shares. Parsons Mgmt Ri invested 0.78% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Cwm Ltd invested in 710 shares or 0.01% of the stock. 115,527 are held by Pax World Mngmt Ltd Limited Liability Company. Trustmark Savings Bank Tru Department stated it has 2,857 shares or 0.06% of all its holdings. Westfield Cap Limited Partnership holds 30,161 shares. Evercore Wealth Management Ltd Com invested 2.21% in Thermo Fisher Scientific Inc. (NYSE:TMO). Financial Counselors invested in 0.55% or 63,244 shares.

Smith Salley & Associates increased its stake in Thermo Fisher Scientific Inc (TMO) by 1159.71% based on its latest 2017Q2 regulatory filing with the SEC. Smith Salley & Associates bought 25,270 shares as the company’s stock rose 8.13% with the market. The institutional investor held 27,449 shares of the industrial machinery and components company at the end of 2017Q2, valued at $4.79 million, up from 2,179 at the end of the previous reported quarter. Smith Salley & Associates who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be bullish on the $74.44 billion market cap company. The stock increased 0.96% or $1.76 during the last trading session, reaching $185.63. About 1.55M shares traded or 2.45% up from the average. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since December 8, 2016 and is uptrending. It has underperformed by 1.13% the S&P500.

Smith Salley & Associates, which manages about $331.94 million and $497.44 million US Long portfolio, decreased its stake in American Intl Group Inc (NYSE:AIG) by 71,436 shares to 92,545 shares, valued at $5.79 million in 2017Q2, according to the filing.

More important recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: which released: “Thermo Fisher Scientific Acquires Continuous Emission Monitoring Assets from …” on December 04, 2017, also published article titled: “Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific”, published: “Earnings Visibility Keep Thermo Fisher Scientific (TMO) a Buy” on November 09, 2017. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) was released by: and their article: “Thermo Fisher Scientific (TMO) Ranking Raised to Buy on Strong Earnings Growth” with publication date: November 30, 2017.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 17 analysts covering Thermo Fisher Scientific (NYSE:TMO), 16 have Buy rating, 0 Sell and 1 Hold. Therefore 94% are positive. Thermo Fisher Scientific had 51 analyst reports since July 24, 2015 according to SRatingsIntel. Jefferies maintained Thermo Fisher Scientific Inc. (NYSE:TMO) on Tuesday, August 22 with “Hold” rating. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Goldman Sachs on Tuesday, September 26. The company was maintained on Monday, October 2 by Robert W. Baird. The company was maintained on Friday, September 8 by Cowen & Co. Mizuho maintained Thermo Fisher Scientific Inc. (NYSE:TMO) on Thursday, July 23 with “Buy” rating. Jefferies maintained the shares of TMO in report on Friday, October 20 with “Hold” rating. Deutsche Bank initiated Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Thursday, January 7. Deutsche Bank has “Buy” rating and $160 target. As per Thursday, October 26, the company rating was maintained by Deutsche Bank. The firm has “Buy” rating given on Monday, January 11 by Stifel Nicolaus. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Hold” rating by Jefferies on Wednesday, September 27.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: